Cargando…

Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease

BACKGROUND: Peripheral artery disease (PAD) of the lower limbs is a common condition that can affect quality of life. Androgen receptor (AR) can exert sex-specific effects on metabolic system, endothelial function and vascular tone. IGF-I receptor (IGF-IR) and insulin receptor (IR) may also be invol...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreucci, Michele, Rigiracciolo, Damiano Cosimo, Bracale, Umberto Marcello, Ielapi, Nicola, Provenzano, Michele, D'Iuorno, Diletta, Michael, Ashour, Mastroroberto, Pasquale, Serraino, Giuseppe Filiberto, Maggiolini, Marcello, Serra, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760540/
https://www.ncbi.nlm.nih.gov/pubmed/35059526
http://dx.doi.org/10.1016/j.heliyon.2022.e08756
_version_ 1784633342191206400
author Andreucci, Michele
Rigiracciolo, Damiano Cosimo
Bracale, Umberto Marcello
Ielapi, Nicola
Provenzano, Michele
D'Iuorno, Diletta
Michael, Ashour
Mastroroberto, Pasquale
Serraino, Giuseppe Filiberto
Maggiolini, Marcello
Serra, Raffaele
author_facet Andreucci, Michele
Rigiracciolo, Damiano Cosimo
Bracale, Umberto Marcello
Ielapi, Nicola
Provenzano, Michele
D'Iuorno, Diletta
Michael, Ashour
Mastroroberto, Pasquale
Serraino, Giuseppe Filiberto
Maggiolini, Marcello
Serra, Raffaele
author_sort Andreucci, Michele
collection PubMed
description BACKGROUND: Peripheral artery disease (PAD) of the lower limbs is a common condition that can affect quality of life. Androgen receptor (AR) can exert sex-specific effects on metabolic system, endothelial function and vascular tone. IGF-I receptor (IGF-IR) and insulin receptor (IR) may also be involved in the aforementioned functions. The aim of this study was to evaluate AR, IGF-IR and IR expression in the arterial vessel walls of PAD patients. RESULTS: This is a cross-sectional study examining 30 males with PAD undergoing open surgery procedures. Mean age was 75.9 ± 8.8y. All patients belonged to Rutherford stage 4–6. Median expression levels of IR, IGF-IR and AR significantly decreased from stage 4–6 (p < 0.05). SIGNIFICANCE: The study evidenced a progressive decrease of IR, IGF-IR and AR expression as the severity of disease increased. Altered levels of IR, IGF-IR and AR following PAD may be useful for the clinical evaluation of these patients.
format Online
Article
Text
id pubmed-8760540
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87605402022-01-19 Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease Andreucci, Michele Rigiracciolo, Damiano Cosimo Bracale, Umberto Marcello Ielapi, Nicola Provenzano, Michele D'Iuorno, Diletta Michael, Ashour Mastroroberto, Pasquale Serraino, Giuseppe Filiberto Maggiolini, Marcello Serra, Raffaele Heliyon Research Article BACKGROUND: Peripheral artery disease (PAD) of the lower limbs is a common condition that can affect quality of life. Androgen receptor (AR) can exert sex-specific effects on metabolic system, endothelial function and vascular tone. IGF-I receptor (IGF-IR) and insulin receptor (IR) may also be involved in the aforementioned functions. The aim of this study was to evaluate AR, IGF-IR and IR expression in the arterial vessel walls of PAD patients. RESULTS: This is a cross-sectional study examining 30 males with PAD undergoing open surgery procedures. Mean age was 75.9 ± 8.8y. All patients belonged to Rutherford stage 4–6. Median expression levels of IR, IGF-IR and AR significantly decreased from stage 4–6 (p < 0.05). SIGNIFICANCE: The study evidenced a progressive decrease of IR, IGF-IR and AR expression as the severity of disease increased. Altered levels of IR, IGF-IR and AR following PAD may be useful for the clinical evaluation of these patients. Elsevier 2022-01-12 /pmc/articles/PMC8760540/ /pubmed/35059526 http://dx.doi.org/10.1016/j.heliyon.2022.e08756 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Andreucci, Michele
Rigiracciolo, Damiano Cosimo
Bracale, Umberto Marcello
Ielapi, Nicola
Provenzano, Michele
D'Iuorno, Diletta
Michael, Ashour
Mastroroberto, Pasquale
Serraino, Giuseppe Filiberto
Maggiolini, Marcello
Serra, Raffaele
Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease
title Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease
title_full Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease
title_fullStr Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease
title_full_unstemmed Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease
title_short Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease
title_sort assessment of androgen receptor, igf-ir and insulin receptor expression in male patients with severe peripheral artery disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760540/
https://www.ncbi.nlm.nih.gov/pubmed/35059526
http://dx.doi.org/10.1016/j.heliyon.2022.e08756
work_keys_str_mv AT andreuccimichele assessmentofandrogenreceptorigfirandinsulinreceptorexpressioninmalepatientswithsevereperipheralarterydisease
AT rigiracciolodamianocosimo assessmentofandrogenreceptorigfirandinsulinreceptorexpressioninmalepatientswithsevereperipheralarterydisease
AT bracaleumbertomarcello assessmentofandrogenreceptorigfirandinsulinreceptorexpressioninmalepatientswithsevereperipheralarterydisease
AT ielapinicola assessmentofandrogenreceptorigfirandinsulinreceptorexpressioninmalepatientswithsevereperipheralarterydisease
AT provenzanomichele assessmentofandrogenreceptorigfirandinsulinreceptorexpressioninmalepatientswithsevereperipheralarterydisease
AT diuornodiletta assessmentofandrogenreceptorigfirandinsulinreceptorexpressioninmalepatientswithsevereperipheralarterydisease
AT michaelashour assessmentofandrogenreceptorigfirandinsulinreceptorexpressioninmalepatientswithsevereperipheralarterydisease
AT mastrorobertopasquale assessmentofandrogenreceptorigfirandinsulinreceptorexpressioninmalepatientswithsevereperipheralarterydisease
AT serrainogiuseppefiliberto assessmentofandrogenreceptorigfirandinsulinreceptorexpressioninmalepatientswithsevereperipheralarterydisease
AT maggiolinimarcello assessmentofandrogenreceptorigfirandinsulinreceptorexpressioninmalepatientswithsevereperipheralarterydisease
AT serraraffaele assessmentofandrogenreceptorigfirandinsulinreceptorexpressioninmalepatientswithsevereperipheralarterydisease